Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene

Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene

Patient-specific hiPSCs (NCCDFWi001-A) were generated from a patient with Marfan syndrome carrying a compound heterozygous variant (c.684_736 + 4del, p.Pro228fs and c.2613A>C, p.Leu871Phe). Here, we used CRISPR/ Cas9 to correct the FBN1 c.2613A>C variant, which generated an hiPSC line (NCCDFWi...

Full description

Bibliographic Details
Main Authors: Tianjiao Li, Baihui Ma, Hang Yang, Guoyan Zhu, Chang Shu, Mingyao Luo, Zhou Zhou
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506121003901
id doaj-e6a22aa03f4a47848db11e4ec766c276
record_format Article
spelling doaj-e6a22aa03f4a47848db11e4ec766c2762021-09-29T04:24:32ZengElsevierStem Cell Research1873-50612021-10-0156102543Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) geneTianjiao Li0Baihui Ma1Hang Yang2Guoyan Zhu3Chang Shu4Mingyao Luo5Zhou Zhou6State Key Laboratory of Cardiovascular Disease, Beijing Key Laboratory for Molecular Diagnostics of Cardiovascular Diseases, Diagnostic Laboratory Service, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaState Key Laboratory of Cardiovascular Disease, Beijing Key Laboratory for Molecular Diagnostics of Cardiovascular Diseases, Diagnostic Laboratory Service, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaState Key Laboratory of Cardiovascular Disease, Beijing Key Laboratory for Molecular Diagnostics of Cardiovascular Diseases, Diagnostic Laboratory Service, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaState Key Laboratory of Cardiovascular Disease, Beijing Key Laboratory for Molecular Diagnostics of Cardiovascular Diseases, Diagnostic Laboratory Service, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaState Key Laboratory of Cardiovascular Disease, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaState Key Laboratory of Cardiovascular Disease, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaState Key Laboratory of Cardiovascular Disease, Beijing Key Laboratory for Molecular Diagnostics of Cardiovascular Diseases, Diagnostic Laboratory Service, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China; Corresponding author.Patient-specific hiPSCs (NCCDFWi001-A) were generated from a patient with Marfan syndrome carrying a compound heterozygous variant (c.684_736 + 4del, p.Pro228fs and c.2613A>C, p.Leu871Phe). Here, we used CRISPR/ Cas9 to correct the FBN1 c.2613A>C variant, which generated an hiPSC line (NCCDFWi001-A-1) that maintained normal karyotype, pluripotency markers and demonstrated potential for trilineage differentiation.http://www.sciencedirect.com/science/article/pii/S1873506121003901
collection DOAJ
language English
format Article
sources DOAJ
author Tianjiao Li
Baihui Ma
Hang Yang
Guoyan Zhu
Chang Shu
Mingyao Luo
Zhou Zhou
spellingShingle Tianjiao Li
Baihui Ma
Hang Yang
Guoyan Zhu
Chang Shu
Mingyao Luo
Zhou Zhou
Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene
Stem Cell Research
author_facet Tianjiao Li
Baihui Ma
Hang Yang
Guoyan Zhu
Chang Shu
Mingyao Luo
Zhou Zhou
author_sort Tianjiao Li
title Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene
title_short Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene
title_full Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene
title_fullStr Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene
title_full_unstemmed Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene
title_sort generation of a crispr/cas9-corrected-hipsc (nccdfwi001-a-1) from a marfan syndrome patient hipsc with a heterozygous c.2613a>c variant in the fibrillin 1 (fbn1) gene
publisher Elsevier
series Stem Cell Research
issn 1873-5061
publishDate 2021-10-01
description Patient-specific hiPSCs (NCCDFWi001-A) were generated from a patient with Marfan syndrome carrying a compound heterozygous variant (c.684_736 + 4del, p.Pro228fs and c.2613A>C, p.Leu871Phe). Here, we used CRISPR/ Cas9 to correct the FBN1 c.2613A>C variant, which generated an hiPSC line (NCCDFWi001-A-1) that maintained normal karyotype, pluripotency markers and demonstrated potential for trilineage differentiation.
url http://www.sciencedirect.com/science/article/pii/S1873506121003901
work_keys_str_mv AT tianjiaoli generationofacrisprcas9correctedhipscnccdfwi001a1fromamarfansyndromepatienthipscwithaheterozygousc2613acvariantinthefibrillin1fbn1gene
AT baihuima generationofacrisprcas9correctedhipscnccdfwi001a1fromamarfansyndromepatienthipscwithaheterozygousc2613acvariantinthefibrillin1fbn1gene
AT hangyang generationofacrisprcas9correctedhipscnccdfwi001a1fromamarfansyndromepatienthipscwithaheterozygousc2613acvariantinthefibrillin1fbn1gene
AT guoyanzhu generationofacrisprcas9correctedhipscnccdfwi001a1fromamarfansyndromepatienthipscwithaheterozygousc2613acvariantinthefibrillin1fbn1gene
AT changshu generationofacrisprcas9correctedhipscnccdfwi001a1fromamarfansyndromepatienthipscwithaheterozygousc2613acvariantinthefibrillin1fbn1gene
AT mingyaoluo generationofacrisprcas9correctedhipscnccdfwi001a1fromamarfansyndromepatienthipscwithaheterozygousc2613acvariantinthefibrillin1fbn1gene
AT zhouzhou generationofacrisprcas9correctedhipscnccdfwi001a1fromamarfansyndromepatienthipscwithaheterozygousc2613acvariantinthefibrillin1fbn1gene
_version_ 1716864824566087680

Similar Items